Advertisement

Mycopathologia

, Volume 181, Issue 1–2, pp 9–15 | Cite as

Essential Oils for Treatment for Onychomycosis: A Mini-Review

  • Fernanda C. Flores
  • Ruy C. R. Beck
  • Cristiane de B. da SilvaEmail author
Article

Abstract

Onychomycosis are fungal infections affecting finger and toenails mainly caused by dermatophyte fungi and some Candida species. Low cure rates and frequent recurrence, development of a fungal resistance front to various antimicrobial agents topical and systemic, and an ineffective topical treatment make onychomycosis difficult to treat. Essential oils are excellent candidates for the topical treatment for onychomycosis because the development of resistance by fungi is rare, and the presence of side effects is low. They are composed of a complex variety of compounds, mainly terpenes, with low molecular weight, which may easily penetrate into the nail plate, finding the fungi elements. The complex mixture confers a broad antifungal spectrum of action, through interaction with biological membranes, interference in radical and enzymatic reaction of fungi cells. Essential oils may become the source of new therapeutic molecules, and the use of an essential oil incorporated into a topical formulation is an interesting, safe, and effective alternative for the treatment for onychomycosis. However, studies are needed to evaluate the efficacy of essential oils in the treatment for onychomycosis in vivo. This mini-review aims to present the potential use of essential oils for the treatment for onychomycosis, focusing on the last decade.

Keywords

Essential oil Onychomycosis Antifungal Topic treatment Terpenes 

Notes

Acknowledgments

Fernanda thanks to Coordenação de Aperfeiçoamento Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and to Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS) for her scholarship. In addition, the authors thank to Susan Reid for English support.

References

  1. 1.
    Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv. 2008;5:1267–82.CrossRefPubMedGoogle Scholar
  2. 2.
    Gupta AK, Tu LQ. Therapies for onychomycosis: a review. Dermatol Clin. 2006;24:375–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Gupta AK, Simpson FC. New pharmacotherapy for the treatment of onychomycosis: an update. Expert Opin Pharmacother. 2015;16(2):227–36.CrossRefPubMedGoogle Scholar
  4. 4.
    Hammer KA, Carson CF. Antibacterial and antifungal activities of essential oils. In: Thormar H, editor. Lipids and essential oils as antimicrobial agents. Chichester, UK: John Wiley & Sons, Ltd; 2011. p. 255–95.Google Scholar
  5. 5.
    Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils: a review. Food Chem Toxicol. 2008;46:446–75.CrossRefPubMedGoogle Scholar
  6. 6.
    Pinto E, Pina-Vaz C, Salgueiro L, Gonçalves MJ, Costa-de-Oliveira S, Cavaleiro C, Palmeira A, Rodrigues A, Martinez-de-Oliveira J. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J Med Microbiol. 2006;55:1367–73.CrossRefPubMedGoogle Scholar
  7. 7.
    Yahyazadeh M, Omidbaigi R, Zare R, Taheri H. Effect of some essential oils on mycelial growth of Penicillium digitatum. World J Microbiol Biotechnol. 2008;24:1445–50.CrossRefGoogle Scholar
  8. 8.
    Miron D, Battisti F, Silva FK, Lana AD, Pippi B, Casanova B, Gnoatto S, Fuentefria A, Mayorga P, Schapoval EES. Antifungal activity and mechanism of action of monoterpenes against dermatophytes and yeasts. Rev Bras Farmacogn. 2014;24:660–7.CrossRefGoogle Scholar
  9. 9.
    Inouye S, Takahashi M, Abe S. Inhibitory activity of hydrosols, herbal teas and related essential oils against filament formation and the growth of Candida albicans. Jpn J Med Mycol. 2009;50:243–51.CrossRefGoogle Scholar
  10. 10.
    Pinto E, Hrimpeng K, Lopes G, Vaz S, Gonçalves MJ, Cavaleiro C, Salgueiro L. Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species. Eur J Clin Microbiol Infect Dis. 2013;32:1311–20.CrossRefPubMedGoogle Scholar
  11. 11.
    Zuzarte M, Gonçalves MJ, Cavaleiro C, Canhoto J, Vale-Silva L, Silva MJ, Pinto E, Salgueiro L. Chemical composition and antifungal activity of the essential oils of Lavandula viridis L’Hér. J Med Microbiol. 2011;60:612–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Raut JS, Karuppayil SM. A status review on the medicinal properties of essential oils. Ind Crop Prod. 2014;62:250–64.CrossRefGoogle Scholar
  13. 13.
    Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Appl Microbiol. 2009;58:1454–62.Google Scholar
  14. 14.
    Chaieb K, Zmantar T, Ksouri R, Hajlaoui H, Mahdouani K, Abdelly C, Bakhrouf A. Antioxidant properties of the essential oil of Eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. Mycoses. 2007;50:403–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Tullio V, Nostro A, Mandras N, Dugo P, Banche G, Cannatelli MA, Cuffini AM, Alonzo V, Carlone NA. Antifungal activity of essential oils against filamentous fungi determined by broth microdilution and vapour contact methods. J Appl Microbiol. 2007;102:1544–50.CrossRefPubMedGoogle Scholar
  16. 16.
    Gayoso CW, Lima EO, Oliveira VT, Pereira FO, Souza EL, Lima IO, Navarro DF. Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol. Fitoterapia. 2005;76:247–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Martins N, Ferreira ICFR, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, prevention, Diagnosis and alternative treatment. Mycopathologia. 2014;177:223–40.CrossRefPubMedGoogle Scholar
  18. 18.
    Finch JJ, Warshaw EM. Toenail onychomycosis: current and future treatment options. Dermatol Ther. 2007;20:31–46.CrossRefPubMedGoogle Scholar
  19. 19.
    Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19(1):50–62.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Benger S, Townsend P, Ashford RL, Lambert P. An in vitro study to determine the minimum inhibitory concentration of Melaleuca alternifolia against the dermatophyte Trichophyton rubrum. Foot. 2004;14:86–91.CrossRefGoogle Scholar
  21. 21.
    Inouye S, Nishiyama Y, Hasumi KUY, Yamaguchi H, Abe S. The vapor activity of oregano, perilla, tea tree, lavender, clove, and geranium oils against a Trichophyton mentagrophytes in a closed box. J Infect Chemother. 2006;12:349–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Flores FC, de Lima JA, Ribeiro RF, Alves SH, Rolim CMB, Beck RCR, da Silva CB. Antifungal activity of nanocapsule suspensions containing tea tree oil on the growth of Trichophyton rubrum. Mycopathologia. 2013;175:281–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Henri I, Bassolé N, Juliani R. Essential oils in combination and their antimicrobial properties molecules. 2012;17:3989–4006.Google Scholar
  24. 24.
    Gonçalves MJ, Cruz MT, Cavaleiro C, Lopes MC, Salgueiro L. Chemical, antifungal and cytotoxic evaluation of the essential oil of Thymus zygis subsp. silvestris. Ind Crop Prod. 2010;32:70–5.CrossRefGoogle Scholar
  25. 25.
    Gallucci MN, Carezzano ME, Oliva MM, Demo MS, Pizzolitto RP, Zunino MP, Zygadlo JA, Dambolena JS. In vitro activity of natural phenolic compounds against fluconazole-resistant Candida species: a quantitative structure—activity relationship analysis. J Appl Microbiol. 2014;116:795–804.CrossRefPubMedGoogle Scholar
  26. 26.
    Olaizola C, Pérez C, Mata-Essayag S, Hartung C, Collela MT, Magaldi S, Rosell A. Experience with thymol in chloroform solution for the treatment of paronychia. Mycopathologia. 2005;159:209–11.CrossRefPubMedGoogle Scholar
  27. 27.
    Lesage-Meessen L, Bou M, Sigoillot JC, Faulds CB, Lomascolo A. Essential oils and distilled straws of lavender and lavandin: a review of current use and potential application in white biotechnology. Appl Microbiol Biotechnol. 2015;99:3375–85.CrossRefPubMedGoogle Scholar
  28. 28.
    Shin S, Lim S. Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp. J Appl Microbiol. 2004;97:1289–96.CrossRefPubMedGoogle Scholar
  29. 29.
    Zuzarte M, Gonçalves MJ, Crus MT, Cavaleiro C, Canhoto J, Vaz S, Pinto E, Salgueiro L. Lavandula luisieri essential oil as a source of antifungal drugs. Food Chem. 2012;135:1505–10.CrossRefPubMedGoogle Scholar
  30. 30.
    Marzoug HNB, Bouajila J, Ennajar M, Lebrihi A, Mathieu F, Couderc F, Abderraba M, Romdhane M. Eucalyptus (gracilis, oleosa, salubris, and salmonophloia) essential oils: their chemical composition and antioxidant and antimicrobial activities. J Med Food. 2010;13(4):1005–12.CrossRefPubMedGoogle Scholar
  31. 31.
    Gupta A, Sharma S, Naik SN. Biopesticidal value of selected essential oils against pathogenic fungus, termites and nematodes. I Biodeterior Biodegrad. 2011;65:703–7.CrossRefGoogle Scholar
  32. 32.
    Elaissi A, Rouis Z, Salem NAB, Mabrouk S, Salem Y, Salah KBH, Aouni M, Farhat F, Chemli R, Harzallah-Skhiri F, Khouja ML. Chemical composition of 8 eucalyptus species’ essential oils and the evaluation of their antibacterial, antifungal and antiviral activities. BMC Complement Altern Med. 2012;12:81.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Ramsewak RS, Nair MG, Stommel M, Selanders L. In vitro antagonistic activity of monoterpenes and their mixtures against ‘toe nail fungus’ pathogens. Phytother Res. 2003;17:376–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Derby SR, Rohal P, Jackson C, Beutler A, Olsen C. Novel treatment of onychomycosis using over-the-counter mentholated ointment: a clinical case. J Am Board Fam Med. 2011;24:69–74.CrossRefPubMedGoogle Scholar
  35. 35.
    Palmeira-de-Oliveira A, Salgueiro L, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Pina-Vaz C, Queiroz JA, Rodrigues AG. Anti-candida activity of essential oils. Mini Rev Med Chem. 2009;9:1292–305.CrossRefPubMedGoogle Scholar
  36. 36.
    Sahin F, Güllüce M, Daferera D, Sökmen A, Polissiou M, Agar G, Hözer H. Biological activities of the essential oils and the methanol extract of Origanum vulgare ssp. vulgare in the Eastern Anatolia region of Turkey. Food Control. 2004;15:549–57.CrossRefGoogle Scholar
  37. 37.
    Vale-Silva L, Silva MJ, Oliveira D, Gonçalves MJ, Cavaleiro C, Salgueiro L, Pinto E. Correlation of the chemical composition of essential oils from Origanum vulgare subsp. virens with their in vitro activity against pathogenic yeasts and filamentous fungi. J Med Microbiol. 2012;61:252–60.CrossRefPubMedGoogle Scholar
  38. 38.
    Pinto E, Salgueiro LR, Cavaleiro C, Palmeira A, Gonçalves MJ. In vitro susceptibility of some species of yeasts and filamentous fungi to essential oils of Salvia officinallis. Ind Crop Prod. 2007;26:135–41.CrossRefGoogle Scholar
  39. 39.
    Ibrahim SY, El-Salam MMA. Anti-dermatophyte efficacy and environmental safety of some essential oils commercial and in vitro extracted pure and combined against four keratinophilic pathogenic fungi. Environ Health Prev Med. 2015; 20(4):279–286.CrossRefPubMedGoogle Scholar
  40. 40.
    Miron D, Cornelio R, Troleis J, Mariath J, Zimmer AR, Mayorga P, Schapoval EES. Influence of penetration enhancers and molecular weight in antifungals permeation through bovine hoof membranes and prediction of efficacy in human nails. Eur J Pharm Sci. 2014;51:20–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Albert SF, Weis ZH. Management of onychomychosis with topicals. Clin Podiatr Med Surg. 2004;21:605–15.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Fernanda C. Flores
    • 1
  • Ruy C. R. Beck
    • 2
  • Cristiane de B. da Silva
    • 1
    • 3
    Email author
  1. 1.Programa de Pós-Graduação em Ciências FarmacêuticasUniversidade Federal de Santa MariaSanta MariaBrazil
  2. 2.Programa de Pós-Graduação em Ciências FarmacêuticasUniversidade Federal do Rio Grande do SulPorto AlegreBrazil
  3. 3.Departamento de Farmácia Industrial, Curso de Farmácia, Centro de Ciências da SaúdeUniversidade Federal de Santa MariaSanta MariaBrazil

Personalised recommendations